Takeda Pharmaceutical Co. Ltd. reported their share repurchase activities from April 1 to April 30, 2025, totaling 11,823,500 shares repurchased for about JPY 49.98 billion, while holding 23,558,061 treasury shares as of April 30, 2025. This report, filed on May 14, 2025, shows significant progress in repurchasing shares authorized during a board meeting on January 30, 2025.